KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Hologic (HOLX) Shares Outstanding (2016 - 2025)

Hologic (HOLX) has disclosed Shares Outstanding for 17 consecutive years, with $302.9 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding changed 0.39% to $302.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $302.9 million through Dec 2025, changed 0.39% year-over-year, with the annual reading at $302.4 million for FY2025, 0.42% changed from the prior year.
  • Shares Outstanding hit $302.9 million in Q4 2025 for Hologic, roughly flat from $302.4 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $302.9 million in Q4 2025 to a low of $40.7 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $287.1 million across 5 years, with a median of $299.9 million in 2023.
  • Biggest five-year swings in Shares Outstanding: surged 726.2% in 2021 and later crashed 83.55% in 2022.
  • Year by year, Shares Outstanding stood at $297.9 million in 2021, then rose by 0.54% to $299.5 million in 2022, then increased by 0.34% to $300.5 million in 2023, then rose by 0.42% to $301.8 million in 2024, then rose by 0.39% to $302.9 million in 2025.
  • Business Quant data shows Shares Outstanding for HOLX at $302.9 million in Q4 2025, $302.4 million in Q3 2025, and $302.1 million in Q2 2025.